2-Aminoindane Stats & Data

2-Aminoindane emerged on the research chemical market around 2003, becoming available primarily through online vendors as a designer drug. As an amphetamine analogue with stimulant properties, it attracted interest within the research chemical community despite very limited documentation of its effects or safety profile. The substance has remained relatively obscure compared to other research chemicals, with sparse information available regarding its recreational use patterns or prevalence. Its availability has been predominantly as an off-white powder marketed through grey market sources, with oral administration being the primary reported route of use.

The toxicity and long-term health effects of recreational 2-AI use do not seem to have been studied in any scientific context and the exact toxic dosage is unknown. This is because 2-AI has very little history of human usage. Anecdotal evidence from people who have tried 2-AI within the community suggest that there do not seem to be any negative health effects attributed to simply trying this drug at low to moderate doses by itself and using it sparingly (but nothing can be completely guaranteed). It is strongly recommended that one use harm reduction practices when using this drug.